No abstract available
MeSH terms
-
Acitretin / administration & dosage
-
Acitretin / adverse effects
-
Acitretin / therapeutic use
-
Adalimumab / administration & dosage
-
Adalimumab / adverse effects
-
Adalimumab / therapeutic use
-
Aged, 80 and over
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Cyclosporine / administration & dosage
-
Cyclosporine / therapeutic use
-
Drug Resistance / physiology
-
Female
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Keratolytic Agents / therapeutic use
-
Methotrexate / administration & dosage
-
Methotrexate / therapeutic use
-
Psoriasis / drug therapy*
-
Psoriasis / pathology
-
Skin Diseases, Vesiculobullous / drug therapy*
-
Skin Diseases, Vesiculobullous / pathology
-
Treatment Outcome
-
Ustekinumab / administration & dosage
-
Ustekinumab / therapeutic use*
Substances
-
Antibodies, Monoclonal, Humanized
-
Immunosuppressive Agents
-
Keratolytic Agents
-
Cyclosporine
-
Ustekinumab
-
Adalimumab
-
Acitretin
-
Methotrexate